News & ViewsNewslettersContactBecome a Research Patient
DHRHealth Institute for Research and Development

Clinical Trial

Use of Monoclonal Antibodies (Casirivimab + Imdevimab) for Post-Exposure Prophylaxis and the Use of Sotrovimab for the Treatment of Mild to Moderate COVID-19 in Non-Hospitalized Setting

Study Status:

Open For Enrollment

Please contact us for more information or to learn if you are eligible to participate.

Study Purpose:

The objective of the project is to Minimize and/or eliminate the number of adults and pediatric patients with mild to moderate COVID-19 (confirmed by positive results of direct SARS-CoV-2 viral testing) who are 12 years of age and older weighing at least 40 kg, who are at high risk for progressing to severe COVID-19 and/ or hospitalization.

Information: 

Principal Investigator
Sohail Rao, MD, MA, DPhil
Sponsor
DHR Health Institute for Research and Development
Type of Trial
Interventional
© 2022 DHR Health Institute for Research & Development | All Rights Reserved | Terms & Conditions | Site By: KangoMedia
chevron-down linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram